Veterinary Pharmacovigilance Market 2024, By Component (Software, Services), By Product Type (Biologics, Anti-infectives, Other Products), By Animal Type (Dogs, Cats, Others), and Region – Global Dynamics, Trends & Forecast

Number of pages: 200+  |  Report Format: PDF  |  Published date: July, 2024
Historical Years – 2018-2022  |  Base Year – 2023  |  Forecasted Years – 2024 to 2033

A new report titled “Veterinary Pharmacovigilance Market – Forecast to 2033” by Eternal Markets, the global Veterinary Pharmacovigilance industry is projected to grow at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2033, reaching a value of USD 2,543.6 million by the end of the forecast period.

Overview

The global veterinary pharmacovigilance market is anticipated to experience significant growth over the forecast period from 2024 to 2033. The increasing awareness of animal health and safety, combined with stringent regulations regarding veterinary drug monitoring, is driving the demand for veterinary pharmacovigilance services and solutions. This market encompasses the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems in animals. Anti-infectives held the largest market share by product type in 2023, and the software segment is expected to be the largest revenue contributor by component in 2033. North America dominated the market in 2023 due to advanced veterinary healthcare infrastructure and robust regulatory frameworks.

Key Visions

  • The estimated CAGR is around 14.4% over the forecast period (2024-2033).
  • The global veterinary pharmacovigilance industry size is projected to reach USD 2,543.6 million by 2033 from USD 745.2 million in 2023.
  • Increasing awareness of animal health and stringent regulations regarding veterinary drug monitoring are key drivers for the market.
  • By product type, in 2023, the anti-infectives segment held the largest market share.
  • Based on the component, the software segment is likely to be the largest revenue contributor in 2033.
  • North America held the largest market share in 2023 due to advanced veterinary healthcare infrastructure and robust regulatory frameworks.

Key Market Drivers

Increasing Awareness of Animal Health: Growing awareness among pet owners and livestock farmers about the importance of animal health and safety is driving the demand for veterinary pharmacovigilance.

Stringent Regulatory Requirements: Regulatory bodies worldwide are enforcing stringent guidelines for the monitoring and reporting of adverse drug reactions in animals, boosting the need for pharmacovigilance services.

Advancements in Pharmacovigilance Software: Technological advancements in pharmacovigilance software are enhancing the efficiency of adverse event reporting and data analysis.

Rising Incidence of Adverse Drug Reactions: An increase in the use of veterinary pharmaceuticals and biologics has led to a higher incidence of adverse drug reactions, necessitating robust pharmacovigilance systems.

Growth in Veterinary Healthcare Expenditure: Increasing expenditure on veterinary healthcare, driven by rising pet ownership and livestock farming, is supporting market growth.

Restraining Factors

Lack of Awareness in Certain Regions: Limited awareness about the importance of pharmacovigilance in veterinary medicine in some regions can hinder market growth.

Complex Regulatory Environment: Navigating the complex regulatory environment for veterinary pharmacovigilance can pose challenges for market players.

Data Privacy Concerns: Concerns regarding data privacy and security can impact the adoption of pharmacovigilance software solutions.

Future Scope

Expansion in Emerging Markets: The veterinary pharmacovigilance market is expected to witness significant growth in emerging markets such as Asia-Pacific and Latin America due to increasing awareness and regulatory developments.

Integration of Artificial Intelligence: The integration of artificial intelligence and machine learning in pharmacovigilance processes will enhance the detection and analysis of adverse drug reactions.

Development of Comprehensive Pharmacovigilance Platforms: The development of integrated and comprehensive pharmacovigilance platforms will streamline the monitoring and reporting processes.

Collaboration with Veterinary Institutions: Increased collaboration between pharmacovigilance service providers and veterinary institutions will drive market expansion.

Focus on Companion Animal Health: The growing focus on companion animal health and the rising prevalence of chronic diseases in pets will create new opportunities in the market.

Major Strategies adopted by key market players.

  • Agreements, Collaborations, and Partnerships: 21%
  • Acquisitions: 15%
  • New Product Launch: _%
  • Other Developments: _%

Geographical Analysis

North America held the largest market share in 2023 due to its advanced veterinary healthcare infrastructure and robust regulatory frameworks. The region’s high awareness of animal health and safety, coupled with significant investments in veterinary pharmacovigilance systems, contributes to its market dominance.

The Asia-Pacific region is expected to witness significant growth during the forecast period, driven by increasing awareness of animal health, rising veterinary healthcare expenditure, and developing regulatory frameworks. Countries such as China, Japan, and India are key contributors to market expansion in this region.

Recent Developments

  • 2023: Azierta Contract Science Support Consulting launched a new pharmacovigilance software platform to enhance adverse event reporting and data analysis.
  • 2022: ArisGlobal announced a strategic partnership with a leading veterinary institution to develop advanced pharmacovigilance solutions.
  • 2021: Ennov introduced a comprehensive pharmacovigilance platform integrating AI and machine learning capabilities.
  • 2020: Biologit expanded its pharmacovigilance services portfolio to include advanced data analytics and reporting tools.

Scope of the Report:

Global Veterinary Pharmacovigilance Market, By Component

  • Software
  • Services

Global Veterinary Pharmacovigilance Market, By Product Type

  • Biologics
  • Anti-infectives
  • Other Products

Global Veterinary Pharmacovigilance Market, By Animal Type

  • Dogs
  • Cats
  • Others

Global Veterinary Pharmacovigilance Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • GCC
    • Israel
    • South Africa
    • Rest of MEA

Companies Profiled

● Azierta Contract Science Support Consulting
● Oy Medfiles Ltd.
● ArisGlobal
● Accenture
● Biologit
● Indivirtus
● Ennov
● Pharsafer Associates Limited
● Knoell
● Sarjen Systems Pvt. Ltd.
● Other key players

*The report scope shall be customized as per the requirements

Chapter 1 Global Veterinary Pharmacovigilance Market Overview
1.1 Introduction
1.2 Drivers for Veterinary Pharmacovigilance Market
1.3 Restraints for Veterinary Pharmacovigilance Market
1.4 Opportunities for Veterinary Pharmacovigilance Market
1.5 Trends for Veterinary Pharmacovigilance Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Veterinary Pharmacovigilance Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Azierta Contract Science Support Consulting
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Oy Medfiles Ltd.
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 ArisGlobal
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Accenture
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Biologit
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Indivirtus
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Ennov
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Pharsafer Associates Limited
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Knoell
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Sarjen Systems Pvt. Ltd.
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Veterinary Pharmacovigilance Market Overview
3.1 Global Veterinary Pharmacovigilance Market Outlook (2017-2032)
3.1.1 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Veterinary Pharmacovigilance Market by Region
3.2.1 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Veterinary Pharmacovigilance Market by Component
3.3.1 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2032)
3.3.2 Global Veterinary Pharmacovigilance Market Attractiveness Analysis by Component, 2023–2032
3.3.3 Global Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Veterinary Pharmacovigilance Market by Product Type
3.4.1 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
3.4.2 Global Veterinary Pharmacovigilance Market Attractiveness Analysis by Product Type, 2023–2032
3.5 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Component
3.6.1 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2023)
3.6.2 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2024-2032)
3.7 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Product Type
3.7.1 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
3.7.2 Global Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
3.8 Global Veterinary Pharmacovigilance Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Region
3.8.2 Global Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Component
3.8.3 Global Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Product Type
3.9 Global Veterinary Pharmacovigilance Market Share Comparison 2017–2032
3.9.1 Global Veterinary Pharmacovigilance Market Share by Region
3.9.2 Global Veterinary Pharmacovigilance Market Share by Component
3.9.3 Global Veterinary Pharmacovigilance Market Share by Product Type
Chapter 4 North America Veterinary Pharmacovigilance Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Veterinary Pharmacovigilance Market Outlook (2017-2032)
4.2.1 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Veterinary Pharmacovigilance Market by Region
4.3.1 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Veterinary Pharmacovigilance Market by Component
4.4.1 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2032)
4.4.2 North America Veterinary Pharmacovigilance Market Attractiveness Analysis by Component, 2023–2032
4.4.3 North America Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Veterinary Pharmacovigilance Market by Product Type
4.5.1 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
4.5.2 North America Veterinary Pharmacovigilance Market Attractiveness Analysis by Product Type, 2023–2032
4.6 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Component
4.7.1 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2023)
4.7.2 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2024-2032)
4.8 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Product Type
4.8.1 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
4.8.2 North America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
4.9 North America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Region
4.9.2 North America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Component
4.9.3 North America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Product Type
4.1 North America Veterinary Pharmacovigilance Market Share Comparison 2017–2032
4.10.1 North America Veterinary Pharmacovigilance Market Share by Region
4.10.2 North America Veterinary Pharmacovigilance Market Share by Component
4.10.3 North America Veterinary Pharmacovigilance Market Share by Product Type
Chapter 5 Europe Veterinary Pharmacovigilance Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Veterinary Pharmacovigilance Market Outlook (2017-2032)
5.2.1 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Veterinary Pharmacovigilance Market by Region
5.3.1 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Veterinary Pharmacovigilance Market by Component
5.4.1 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2032)
5.4.2 Europe Veterinary Pharmacovigilance Market Attractiveness Analysis by Component, 2023–2032
5.4.3 Europe Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Veterinary Pharmacovigilance Market by Product Type
5.5.1 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
5.5.2 Europe Veterinary Pharmacovigilance Market Attractiveness Analysis by Product Type, 2023–2032
5.6 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Component
5.7.1 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2023)
5.7.2 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2024-2032)
5.8 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Product Type
5.8.1 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
5.8.2 Europe Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
5.9 Europe Veterinary Pharmacovigilance Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Region
5.9.2 Europe Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Component
5.9.3 Europe Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Product Type
5.1 Europe Veterinary Pharmacovigilance Market Share Comparison 2017–2032
5.10.1 Europe Veterinary Pharmacovigilance Market Share by Region
5.10.2 Europe Veterinary Pharmacovigilance Market Share by Component
5.10.3 Europe Veterinary Pharmacovigilance Market Share by Product Type
Chapter 6 Asia Pacific Veterinary Pharmacovigilance Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Veterinary Pharmacovigilance Market Outlook (2017-2032)
6.2.1 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Veterinary Pharmacovigilance Market by Region
6.3.1 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Veterinary Pharmacovigilance Market by Component
6.4.1 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2032)
6.4.2 Asia Pacific Veterinary Pharmacovigilance Market Attractiveness Analysis by Component, 2023–2032
6.4.3 Asia Pacific Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Veterinary Pharmacovigilance Market by Product Type
6.5.1 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
6.5.2 Asia Pacific Veterinary Pharmacovigilance Market Attractiveness Analysis by Product Type, 2023–2032
6.6 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Component
6.7.1 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2023)
6.7.2 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2024-2032)
6.8 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Product Type
6.8.1 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
6.8.2 Asia Pacific Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
6.9 Asia Pacific Veterinary Pharmacovigilance Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Component
6.9.3 Asia Pacific Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Product Type
6.1 Asia Pacific Veterinary Pharmacovigilance Market Share Comparison 2017–2032
6.10.1 Asia Pacific Veterinary Pharmacovigilance Market Share by Region
6.10.2 Asia Pacific Veterinary Pharmacovigilance Market Share by Component
6.10.3 Asia Pacific Veterinary Pharmacovigilance Market Share by Product Type
Chapter 7 South America Veterinary Pharmacovigilance Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Veterinary Pharmacovigilance Market Outlook (2017-2032)
7.2.1 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Veterinary Pharmacovigilance Market by Region
7.3.1 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Veterinary Pharmacovigilance Market by Component
7.4.1 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2032)
7.4.2 South America Veterinary Pharmacovigilance Market Attractiveness Analysis by Component, 2023–2032
7.4.3 South America Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Veterinary Pharmacovigilance Market by Product Type
7.5.1 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
7.5.2 South America Veterinary Pharmacovigilance Market Attractiveness Analysis by Product Type, 2023–2032
7.6 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Component
7.7.1 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2023)
7.7.2 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2024-2032)
7.8 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Product Type
7.8.1 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
7.8.2 South America Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
7.9 South America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Region
7.9.2 South America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Component
7.9.3 South America Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Product Type
7.1 South America Veterinary Pharmacovigilance Market Share Comparison 2017–2032
7.10.1 South America Veterinary Pharmacovigilance Market Share by Region
7.10.2 South America Veterinary Pharmacovigilance Market Share by Component
7.10.3 South America Veterinary Pharmacovigilance Market Share by Product Type
Chapter 8 Middle East and Africa Veterinary Pharmacovigilance Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Veterinary Pharmacovigilance Market Outlook (2017-2032)
8.2.1 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Veterinary Pharmacovigilance Market by Region
8.3.1 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Veterinary Pharmacovigilance Market by Component
8.4.1 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2032)
8.4.2 Middle East and Africa Veterinary Pharmacovigilance Market Attractiveness Analysis by Component, 2023–2032
8.4.3 Middle East and Africa Veterinary Pharmacovigilance Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Veterinary Pharmacovigilance Market by Product Type
8.5.1 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
8.5.2 Middle East and Africa Veterinary Pharmacovigilance Market Attractiveness Analysis by Product Type, 2023–2032
8.6 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Component
8.7.1 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2017-2023)
8.7.2 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Component (2024-2032)
8.8 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) by Product Type
8.8.1 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
8.8.2 Middle East and Africa Veterinary Pharmacovigilance Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
8.9 Middle East and Africa Veterinary Pharmacovigilance Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Component
8.9.3 Middle East and Africa Veterinary Pharmacovigilance Market Y-o-Y Growth Rate by Product Type
8.1 Middle East and Africa Veterinary Pharmacovigilance Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Veterinary Pharmacovigilance Market Share by Region
8.10.2 Middle East and Africa Veterinary Pharmacovigilance Market Share by Component
8.10.3 Middle East and Africa Veterinary Pharmacovigilance Market Share by Product Type
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

License

Single User, Corporate User, Data Pack / Excel
Single User
$3,499
Corporate User
$6,999
Data Pack / Excel
$999
Compare Added ♡ Add to Wishlist♥ Browse Wishlist

Related products

Compare Products
No products were added to compare list
Return to Shop
Caffeine Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Milk Powder Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Instant Coffee Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Collagen Peptide and Gelatin Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Electrolyte Drinks Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Food Colors Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Used Cooking Oil Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Nutritional Food and Drink Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Dietary Fibers Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Luxury Wines and Spirits Market 2024, Global Dynamics, Trends & Forecast
0 customer review
Luxury Wines and Spirits Market 2024, Global Dynamics, Trends & Forecast
VIEW DETAILS